Cite

HARVARD Citation

    Harel, M. et al. (n.d.). 21 Plasma-based proteomic profiling as a tool for predicting response to immunotherapy in melanoma patients. Journal for immunotherapy of cancer. pp. A11-A12. [Online]. 
  
Back to record